RHON-KLINIKUM AG Unsponsored ADR
RKAGY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $752 | $655 | $811 | $1,024 |
| - Cash | $280 | $206 | $77 | $126 |
| + Debt | $150 | $150 | $158 | $160 |
| Enterprise Value | $622 | $599 | $892 | $1,058 |
| Revenue | $1,596 | $1,464 | $1,446 | $1,591 |
| % Growth | 9% | 1.2% | -9.1% | – |
| Gross Profit | $172 | $149 | $1,000 | $183 |
| % Margin | 10.8% | 10.2% | 69.1% | 11.5% |
| EBITDA | $122 | $117 | $98 | $100 |
| % Margin | 7.7% | 8% | 6.8% | 6.3% |
| Net Income | $43 | $39 | $25 | $28 |
| % Margin | 2.7% | 2.6% | 1.7% | 1.8% |
| EPS Diluted | 0.34 | 0.29 | 0.19 | 0.21 |
| % Growth | 17.2% | 52.6% | -9.5% | – |
| Operating Cash Flow | $128 | $109 | $41 | $98 |
| Capital Expenditures | -$70 | -$63 | -$58 | -$78 |
| Free Cash Flow | $57 | $46 | -$17 | $20 |